Literature DB >> 2448954

Evidence that immunological variants of p53 represent alternative protein conformations.

J Gamble1, J Milner.   

Abstract

In normal murine lymphocytes the cellular oncoprotein, p53, exists as two immunologically distinct species which are reciprocally expressed in quiescent (p53-Go) and mitogenically stimulated (p53-G divided by) cells. More recently, we have identified discrete forms of p53, immunologically similar to p53-Go and p53-G divided by, in 3T3 cells transformed by simian virus 40 (SV40). In this report, we demonstrate that immunologically distinct p53 species can also be expressed in vitro, from a single murine p53 cDNA clone. The p53 variants expressed in vitro and in SV40-transformed 3T3 cells have been studied by immunoprecipitation and Western blotting. Immunoprecipitation data indicated that, in their native conformations, the p53 variants react with either the PAb421 or RA3.2C2 monoclonal antibodies, but not with both. When analyzed by Western blotting, however, the denatured proteins were found to react with both monoclonal antibodies. This suggests that the p53 protein is flexible and can fold in alternative conformations so as to expose or mask different epitopes. We propose, therefore, that immunologically distinct p53 species are generated, at least partly, by conformational changes in a single polypeptide species.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2448954     DOI: 10.1016/0042-6822(88)90486-2

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  9 in total

1.  Tumor suppressor p53: analysis of wild-type and mutant p53 complexes.

Authors:  J Milner; E A Medcalf; A C Cook
Journal:  Mol Cell Biol       Date:  1991-01       Impact factor: 4.272

2.  Synergy between the Mos/mitogen-activated protein kinase pathway and loss of p53 function in transformation and chromosome instability.

Authors:  K Fukasawa; G F Vande Woude
Journal:  Mol Cell Biol       Date:  1997-01       Impact factor: 4.272

3.  Evidence for allosteric variants of wild-type p53, a tumour suppressor protein.

Authors:  A Cook; J Milner
Journal:  Br J Cancer       Date:  1990-04       Impact factor: 7.640

4.  p53 is associated with p34cdc2 in transformed cells.

Authors:  J Milner; A Cook; J Mason
Journal:  EMBO J       Date:  1990-09       Impact factor: 11.598

5.  Identification of tumour-associated and germ line p53 mutations in canine mammary cancer.

Authors:  N Veldhoen; J Watterson; M Brash; J Milner
Journal:  Br J Cancer       Date:  1999-10       Impact factor: 7.640

6.  Interdiction in the Early Folding of the p53 DNA-Binding Domain Leads to Its Amyloid-Like Misfolding.

Authors:  Fernando Bergasa-Caceres; Herschel A Rabitz
Journal:  Molecules       Date:  2022-07-27       Impact factor: 4.927

7.  Interaction of heat-shock protein 70 with p53 translated in vitro: evidence for interaction with dimeric p53 and for a role in the regulation of p53 conformation.

Authors:  P Hainaut; J Milner
Journal:  EMBO J       Date:  1992-10       Impact factor: 11.598

8.  Analysis of the most representative tumour-derived p53 mutants reveals that changes in protein conformation are not correlated with loss of transactivation or inhibition of cell proliferation.

Authors:  K Ory; Y Legros; C Auguin; T Soussi
Journal:  EMBO J       Date:  1994-08-01       Impact factor: 11.598

9.  Temperature sensitivity for conformation is an intrinsic property of wild-type p53.

Authors:  P Hainaut; S Butcher; J Milner
Journal:  Br J Cancer       Date:  1995-02       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.